Skip to main content
. 2023 Nov 18;13:20213. doi: 10.1038/s41598-023-47611-w

Table 5.

The effect of infection history on antibody titer in 3 vaccine types.

Vaccine type After the first dose After second dose
Antibody titer (BAU/ml): Median (IQR 25–75) Antibody titer (BAU/ml): Median (IQR 25–75)
With Inf.h Without inf.h P-value With Inf.h Without inf.h P-value
AstraZeneca 796.8 (376.0–820.0) 152.0 (60.8–387.2)  < 0.001 419.2 (617.6–411.2) 366.4 (252.8–412.8)  < 0.001
COVIran Barekat 150.4 (51.2–323.2) 105.6 (16.0–278.4) 0.232 163.2 (64.8–381.6) 192.0 (72.0–297.6) 0.800
Sinopharm 275.2 (166.4–315.2) 57.6 (15.2–262.4) 0.003 264.0 (134.4–389.6) 176.0 (72.0–300.8) 0.159
Overall 320.0 (212.8–796.8) 105.6 (20.0–299.2)  < 0.001 384.0 (211.2–422.4) 235.2 (96.0–371.2) 0.002

Inf.h, infection history.